(Q38332979)
Statements
1 reference
Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition (English)
1 reference
Hong Min Wu
1 reference
Yoon Mee Yang
1 reference
Sang Geon Kim
1 reference
29 July 2011
1 reference
1 reference
80
1 reference
5
1 reference
859-869
1 reference
Identifiers
1 reference
1 reference